Panbela Therapeutics, Inc. is a biopharmaceutical enterprise currently in clinical development, along with its subsidiaries, dedicated to advancing innovative therapies for cancer patients. The company's therapeutic endeavors primarily target pancreatic disorders, including pancreatitis, pancreatic cancer, and neoadjuvant pancreatic cancer. Beyond pancreatic diseases, they are also exploring treatments for colorectal cancer, ovarian cancer, and various other oncology indications.
| Date | Est. | Actual | |
|---|---|---|---|
| Nov 12, 2025 | -$1.63 | -$1.48 | Beat |
| Jul 23, 2025 | -$2.07 | -$1.47 | Beat |
| Jun 12, 2025 | -$1.62 | -$2.28 | Miss |
| Apr 25, 2025 | -$24.34 | -$65.90 | Miss |
| Nov 14, 2024 | -$1.21 | -$1.48 | Miss |
| Aug 13, 2024 | -$1.69 | -$1.47 | Beat |